[Cycloferon in complex therapy management of chronic laryngitis].
The clinical course of various forms of chronic laryngitis, including contact granulomas not only persistant and relapsing, but also inclined to oncologic pathology due to hyperplastic changes in the larynx resulting in malignization was described. Inhibition of the leukocyte interferon-synthesizing activity was observed in more than 88.1% of the subjects. Pathogenic viruses were isolated from 48.2% of the patients, EBV and mycoplasma prevailing. High direct correlation between chronic laryngitis and Herpes viruses was shown. The presence of three-component virus associations in the larynx mucosa was likely indicative of the bening process malignancy. The use of the interferon inductor cycloferon in the complex surgical and medicamentous management of chronic laryngitis was shown valid. The rate of the relapses lowered to 1.7 episodes a year.
E V
EV
Demchenko
M G
MG
Romantsov
S S
SS
Grigorian
A L
AL
Kovalenko
D000166:Acridines / Q000627:therapeutic use*; D000328:Adult; D002908:Chronic Disease; D060085:Coinfection; D020031:Epstein-Barr Virus Infections / Q000276:immunology / Q000382:microbiology / Q000628:therapy* / Q000821:virology; D006099:Granuloma / Q000276:immunology / Q000382:microbiology / Q000628:therapy* / Q000821:virology; D004854:Herpesvirus 4, Human / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D007827:Laryngitis / Q000276:immunology / Q000382:microbiology / Q000628:therapy* / Q000821:virology; D007830:Larynx / Q000187:drug effects / Q000276:immunology / Q000382:microbiology / Q000821:virology; D009174:Mycoplasma / Q000187:drug effects / Q000276:immunology; D009175:Mycoplasma Infections / Q000276:immunology / Q000382:microbiology / Q000628:therapy* / Q000821:virology; D055502:Secondary Prevention; D016896:Treatment Outcome
D000166:Acridines; D007369:Interferon Inducers; C026430:10-carboxymethyl-9-acridanone